Summary
Oxford Immunotec Ltd (Oxford Immunotec) a subsidiary of Oxford Immunotec Global Plc is a medical device company that offers proprietary tests for immune-regulated conditions. The company offers in vitro diagnostic, T-SPOT CMV Test, C6 Lyme ELISA Test, T-Cell Xtend Reagent. It offers T-SPOT.TB test that diagnoses both latent TB infection and active disease by measuring T cells that have been activated by Mycobacterium tuberculosis antigens. Oxford Immunotec’s T-SPOT solution offers diagnosing disease by measuring immune response to an infection. The company offers laboratories services such as oxford diagnostics. It operates in the US, the UK, Japan, South Korea and China. Oxford Immunotec is headquartered in Abingdon, the UK.
This report is a source for data, analysis, and actionable intelligence on the company’s portfolio of pipeline products. The report provides key information about the company, its major products and brands.
The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage.
Scope:
- The report reviews detailed company profile with information on business description, key company facts, major products and services, key competitors, key employees, locations and subsidiaries and recent developments
- The report analyzes all pipeline products in development for the company Oxford Immunotec Ltd
- The report provides pipeline analysis on all pipeline products of the company (by equipment type, by indication, by development stage, and by trial status)
- The report covers detailed information on each pipeline product with information on pipeline territory, stage of development, device class, regulatory path, indication(s), application(s) and estimated launch date
- The report provides detailed description of products in development, technical specification and functions
- The report also covers ongoing clinical trials (wherever applicable) with information on trial name, trial objective, sponsor, trial design , trial status and phase, estimated start and end date.
Reasons to Buy:
- Develop business strategies by understanding the trends and developments driving the medical devices pipeline and technology landscape
- Design and develop your product development, marketing and sales strategies by understanding the competitor portfolio
- To formulate effective Research & Development strategies
- Develop market-entry and market expansion strategies
- Exploit in-licensing and out-licensing opportunities by identifying products, most likely to ensure a robust return
- Plan mergers and acquisitions effectively by identifying key players of the most promising pipeline
- Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
- Develop competition strategies by identifying the status and likely launch of the competitors’ pipeline products through review of the clinical trials, stage and of development, etc
- Identify, understand and capitalize the next high-value products that your competitor would add in its portfolio
Note: Some sections may be missing if data is unavailable for the company
'
Table of Contents
Table of Contents 2
List of Tables 4
List of Figures 4
Oxford Immunotec Ltd Company Overview 5
Oxford Immunotec Ltd Company Snapshot 5
Oxford Immunotec Ltd Pipeline Products and Ongoing Clinical Trials Overview 5
Oxford Immunotec Ltd – Pipeline Analysis Overview 8
Oxford Immunotec Ltd - Key Facts 8
Oxford Immunotec Ltd - Major Products and Services 9
Oxford Immunotec Ltd Pipeline Products by Development Stage 10
Oxford Immunotec Ltd Pipeline Products Overview 12
Accutix - Tick-borne Disease 12
Accutix - Tick-borne Disease Product Overview 12
B Cell ELISPOT Assay 13
B Cell ELISPOT Assay Product Overview 13
ELISPOT Tumor Assay 14
ELISPOT Tumor Assay Product Overview 14
I-O Monitoring Test 15
I-O Monitoring Test Product Overview 15
Metabovis Assay - Homocysteine 16
Metabovis Assay - Homocysteine Product Overview 16
Nucleic Acid Amplification Test - Babesia 17
Nucleic Acid Amplification Test - Babesia Product Overview 17
Serology Test - Babesia 18
Serology Test - Babesia Product Overview 18
SpiroFind 19
SpiroFind Product Overview 19
Stratokine 20
Stratokine Product Overview 20
T-SPOT.CMV 21
T-SPOT.CMV Product Overview 21
T-SPOT.ICA 22
T-SPOT.ICA Product Overview 22
T-SPOT.PRT 23
T-SPOT.PRT Product Overview 23
UREA And T-SPOT Based Diagnostic Assay - Immunological Disease 24
UREA And T-SPOT Based Diagnostic Assay - Immunological Disease Product Overview 24
UREA And T-SPOT Based Diagnostic Assay - Infectious Disease 25
UREA And T-SPOT Based Diagnostic Assay - Infectious Disease Product Overview 25
Oxford Immunotec Ltd - Key Competitors 26
Oxford Immunotec Ltd - Key Employees 27
Oxford Immunotec Ltd - Locations And Subsidiaries 28
Head Office 28
Other Locations & Subsidiaries 28
Recent Developments 29
Oxford Immunotec Ltd, Recent Developments 29
Jun 05, 2018: Oxford Immunotec Applauds Updated Guidelines from the American Academy of Pediatrics Supporting Expanded Use of the T-SPOT.TB Test 29
Jun 04, 2018: Oxford Immunotec Announces Data Presentations for T-SPOT.CMV Test at the 2018 American Transplant Congress 29
May 22, 2018: Oxford Immunotec Announces Launch of the Accutix Brand 30
May 21, 2018: Oxford Immunotec’s T-SPOT.TB Test Included in the World Health Organization’s First-Ever Essential Diagnostics List 30
May 01, 2018: Oxford Immunotec Reports First Quarter 2018 Financial Results 30
Mar 06, 2018: FDA approves first tests to screen for tickborne parasite in whole blood and plasma to protect the U.S. blood supply 31
Mar 01, 2018: Oxford Immunotec Announces Appointment of Mark Klausner to the Board of Directors 32
Feb 27, 2018: Oxford Immunotec Reports Fourth Quarter and Full Year 2017 Financial Results 32
Jun 22, 2017: Oxford Immunotec Announces National Reimbursement for the T-SPOT.TB Test in France 34
May 02, 2017: Oxford Immunotec Reports First Quarter 2017 Financial Results 34
Appendix 36
Methodology 36
About GlobalData 39
Contact Us 39
Disclaimer 39
List of Tables
Oxford Immunotec Ltd Pipeline Products and Ongoing Clinical Trials Overview 5
Oxford Immunotec Ltd Pipeline Products by Equipment Type 6
Oxford Immunotec Ltd Pipeline Products by Indication 7
Oxford Immunotec Ltd, Key Facts 8
Oxford Immunotec Ltd, Major Products and Services 9
Oxford Immunotec Ltd Number of Pipeline Products by Development Stage 10
Oxford Immunotec Ltd Pipeline Products Summary by Development Stage 11
Accutix - Tick-borne Disease - Product Status 12
Accutix - Tick-borne Disease - Product Description 12
B Cell ELISPOT Assay - Product Status 13
B Cell ELISPOT Assay - Product Description 13
ELISPOT Tumor Assay - Product Status 14
ELISPOT Tumor Assay - Product Description 14
I-O Monitoring Test - Product Status 15
I-O Monitoring Test - Product Description 15
Metabovis Assay - Homocysteine - Product Status 16
Metabovis Assay - Homocysteine - Product Description 16
Nucleic Acid Amplification Test - Babesia - Product Status 17
Nucleic Acid Amplification Test - Babesia - Product Description 17
Serology Test - Babesia - Product Status 18
Serology Test - Babesia - Product Description 18
SpiroFind - Product Status 19
SpiroFind - Product Description 19
Stratokine - Product Status 20
Stratokine - Product Description 20
T-SPOT.CMV - Product Status 21
T-SPOT.CMV - Product Description 21
T-SPOT.ICA - Product Status 22
T-SPOT.ICA - Product Description 22
T-SPOT.PRT - Product Status 23
T-SPOT.PRT - Product Description 23
UREA And T-SPOT Based Diagnostic Assay - Immunological Disease - Product Status 24
UREA And T-SPOT Based Diagnostic Assay - Immunological Disease - Product Description 24
UREA And T-SPOT Based Diagnostic Assay - Infectious Disease - Product Status 25
UREA And T-SPOT Based Diagnostic Assay - Infectious Disease - Product Description 25
Oxford Immunotec Ltd, Key Employees 27
Oxford Immunotec Ltd, Subsidiaries 28
Glossary 38
List of Figures
Oxford Immunotec Ltd Pipeline Products by Equipment Type 6
Oxford Immunotec Ltd Pipeline Products by Development Stage 10
